RESUMO
Myoclonus in the context of COVID-19 is an increasingly recognized condition. The occurrence in an ICU context in hypoxic patients, with metabolic disorders, taking several types of medication, makes difficult to establish a precise cause. Also, the implication of SARS-CoV-2 by direct invasion of the CNS or by immune-mediated phenomena is not yet clear. Currently, a dozen of cases of myoclonus as a predominant clinical manifestation, immune-mediated by SARS-Cov-2 are published. In all these cases, myoclonus was preceded by respiratory or other suggestive symptoms (e.g., anosmia) for this infection making straightforward the causal link. We describe a case of an isolated generalized myoclonus without other clinical complaints nor chest CT scan abnormalities nor SARS-CoV-2 RNA detection on nasopharyngeal swabs and on the CSF, as a para-infectious phenomenon of COVID-19 infection with excellent response to steroids perfusion. This challenging diagnosis was made upon confirmation of seroconversion (serology was negative at admission, then positive for IgM at day 6, then for both IgM and IgG at day 10) underlying that repeating serology is a diagnostic key to capture a similar findings.
Assuntos
COVID-19 , Mioclonia , Humanos , Imunoglobulina M , Mioclonia/diagnóstico por imagem , Mioclonia/etiologia , RNA Viral , SARS-CoV-2 , SoroconversãoRESUMO
BACKGROUND: Myoclonus is an involuntary movement disorder characterized by semirhythmic jerking movements of muscle groups but is rarely seen in association with Chiari malformation type I (CM-1). CM-1 is a frequently encountered clinical entity in pediatric neurosurgery characterized by caudal displacement of the cerebellar tonsils with or without syringomyelia. We report a pediatric patient who presented with upper extremity myoclonus and was found to have CM-1 and a complex septated cervicothoracic syrinx eccentric to the left. CASE PRESENTATION: A 12-year-old female presented with 6 months of headaches and upper extremity paresthesias who subsequently developed a left upper extremity segmental myoclonus after a fall. MRI demonstrated a CM-1 and a large complex cervicothoracic syrinx with a midline and left paracentral cavities. Her myoclonus was nonepileptic and refractory to clonazepam, cyclobenzaprine, and gabapentin. She underwent an intradural Chiari decompression and duraplasty. Postoperatively, she had complete resolution of her segmental myoclonus. DISCUSSION: This case demonstrates a durable resolution of posttraumatic upper extremity segmental myoclonus after surgical decompression of a CM-1 with syringomyelia. Thus, Chiari decompression should be considered in cases of myoclonus with CM-1 and syringomyelia.
Assuntos
Malformação de Arnold-Chiari , Mioclonia , Siringomielia , Adolescente , Malformação de Arnold-Chiari/complicações , Malformação de Arnold-Chiari/diagnóstico por imagem , Malformação de Arnold-Chiari/cirurgia , Criança , Descompressão Cirúrgica , Feminino , Humanos , Imageamento por Ressonância Magnética , Mioclonia/diagnóstico por imagem , Mioclonia/etiologia , Mioclonia/cirurgia , Siringomielia/complicações , Siringomielia/diagnóstico por imagem , Siringomielia/cirurgia , Resultado do Tratamento , Extremidade SuperiorRESUMO
BACKGROUND AND PURPOSE: Post-hypoxic movement disorders and chronic post-hypoxic myoclonus are rare complications after cardiac arrest in adults. Our study investigates the clinical spectrum, neuroimaging results, therapy and prognosis of these debilitating post-hypoxic sequelae. METHODS: This retrospective study included 72 patients from the neurological intensive care unit at a university hospital, who were diagnosed with hypoxic-ischaemic encephalopathy after cardiac arrest between January 2007 and September 2018. Clinical records were screened for occurrence of post-hypoxic movement disorders and chronic post-hypoxic myoclonus. Affected patients were further analysed for applied neuroprognostic tests, administered therapy and treatment response, and the outcome of these movement disorders and neurological function. RESULTS: Nineteen out of 72 screened patients exhibited post-hypoxic motor symptoms. Basal ganglia injury was the most likely neuroanatomical correlate of movement disorders as indicated by T1 hyperintensities and hypometabolism of this region in magnetic resonance imaging and positron emission tomography computed tomography. Levomepromazine and intrathecal baclofen showed first promising and mostly prompt responses to control these post-hypoxic movement disorders and even hyperkinetic storms. In contrast, chronic post-hypoxic myoclonus best responded to co-application of clonazepam, levetiracetam and primidone. Remission rates of post-hypoxic movement disorders and chronic post-hypoxic myoclonus were 58% and 50%, respectively. Affected patients seemed to present a rather good recovery of cognitive functions in contrast to the often more severe physical deficits. CONCLUSIONS: Post-hypoxic movement disorders associated with pronounced basal ganglia dysfunction might be efficiently controlled by levomepromazine or intrathecal baclofen. Their occurrence might be an indicator for a more unfavourable, but often not devastating, neurological outcome.
Assuntos
Lesões Encefálicas , Parada Cardíaca , Transtornos dos Movimentos , Mioclonia , Adulto , Parada Cardíaca/complicações , Humanos , Transtornos dos Movimentos/diagnóstico por imagem , Transtornos dos Movimentos/etiologia , Mioclonia/diagnóstico por imagem , Mioclonia/tratamento farmacológico , Mioclonia/etiologia , Estudos RetrospectivosRESUMO
AIM: The aim of this paper is to describe the clinical features of COVID-19-related encephalopathy and their metabolic correlates using brain 2-desoxy-2-fluoro-D-glucose (FDG)-positron-emission tomography (PET)/computed tomography (CT) imaging. BACKGROUND AND PURPOSE: A variety of neurological manifestations have been reported in association with COVID-19. COVID-19-related encephalopathy has seldom been reported and studied. METHODS: We report four cases of COVID-19-related encephalopathy. The diagnosis was made in patients with confirmed COVID-19 who presented with new-onset cognitive disturbances, central focal neurological signs, or seizures. All patients underwent cognitive screening, brain magnetic resonance imaging (MRI), lumbar puncture, and brain 2-desoxy-2-fluoro-D-glucose (FDG)-positron-emission tomography (PET)/computed tomography (CT) (FDG-PET/CT). RESULTS: The four patients were aged 60 years or older, and presented with various degrees of cognitive impairment, with predominant frontal lobe impairment. Two patients presented with cerebellar syndrome, one patient had myoclonus, one had psychiatric manifestations, and one had status epilepticus. The delay between first COVID-19 symptoms and onset of neurological symptoms was between 0 and 12 days. None of the patients had MRI features of encephalitis nor significant cerebrospinal fluid (CSF) abnormalities. SARS-CoV-2 RT-PCR in the CSF was negative for all patients. All patients presented with a consistent brain FDG-PET/CT pattern of abnormalities, namely frontal hypometabolism and cerebellar hypermetabolism. All patients improved after immunotherapy. CONCLUSIONS: Despite varied clinical presentations, all patients presented with a consistent FDG-PET pattern, which may reflect an immune mechanism.
Assuntos
Encefalopatias/diagnóstico por imagem , COVID-19/complicações , Idoso , Encefalopatias/psicologia , Encefalopatias/terapia , COVID-19/terapia , Doenças Cerebelares/diagnóstico por imagem , Doenças Cerebelares/etiologia , Transtornos Cognitivos/etiologia , Transtornos Cognitivos/psicologia , Feminino , Fluordesoxiglucose F18 , Lobo Frontal/diagnóstico por imagem , Humanos , Imunoterapia , Imageamento por Ressonância Magnética , Masculino , Transtornos Mentais/etiologia , Transtornos Mentais/psicologia , Pessoa de Meia-Idade , Mioclonia/diagnóstico por imagem , Mioclonia/etiologia , Testes Neuropsicológicos , Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada , Compostos Radiofarmacêuticos , Estado Epiléptico/etiologia , Resultado do TratamentoRESUMO
BACKGROUND: The Lance-Adams syndrome (LAS) is a myoclonus syndrome caused by hypoxic-ischemic encephalopathy. LAS cases could be refractory to first-line medications, and the neuronal mechanism underlying LAS pathology remains unknown. OBJECTIVES: To describe a patient with LAS who underwent bilateral globus pallidus internus (GPi) stimulation and discuss the pathophysiology of LAS with intraoperative electrophysiological findings. PATIENTS: A 79-year-old woman presented with a history of cardiopulmonary arrest due to internal carotid artery rupture following carotid endarterectomy after successful cardiopulmonary resuscitation. However, within 1 month, the patient developed sensory stimulation-induced myoclonus in her face and extremities. Because her myoclonic symptoms were refractory to pharmacotherapy, deep brain stimulation of the GPi was performed 1 year after the hypoxic attack. RESULTS: Continuous bilateral GPi stimulation with optimal parameter settings remarkably improved the patient's myoclonic symptoms. At the 2-year follow-up, her Unified Myoclonus Rating Scale score decreased from 90 to 24. In addition, we observed burst firing and interburst pause patterns on intraoperative microelectrode recordings of the bilateral GPi and stimulated this area as the therapeutic target. CONCLUSION: Our results show that impairment in the basal ganglion circuitry might be involved in the pathogenesis of myoclonus in patients with LAS.
Assuntos
Estimulação Encefálica Profunda/métodos , Globo Pálido/fisiologia , Hipóxia-Isquemia Encefálica/terapia , Monitorização Neurofisiológica Intraoperatória/métodos , Mioclonia/terapia , Idoso , Feminino , Globo Pálido/diagnóstico por imagem , Humanos , Hipóxia-Isquemia Encefálica/complicações , Hipóxia-Isquemia Encefálica/diagnóstico por imagem , Microeletrodos , Mioclonia/diagnóstico por imagem , Mioclonia/etiologia , Resultado do TratamentoRESUMO
Tinnitus is one of the most represented otological symptom, affecting 15% of adults, worldwide. Literature describes subjective tinnitus when it's perceived by the patient only, and objective tinnitus when it's heard both, by patient and examiner. An objective tinnitus can be caused by a large variety of anomalies and diseases; one of them is Palatal Myoclonus, characterized by rhytmic movements of soft palatal muscles and, only occasionally, involving other near districts. Case presentation. We observed a rare case of essential palatal myoclonus in a 54 y.o. female, suffering from chronic objective bilateral tinnitus, since 35â¯years, who underwent a wide number of clinical evaluations over the years, without receiving any conclusive diagnosis. In this video, we illustrate all the districts involved in clonic movements: soft palate, larynx and nasal wings. At the same time, we report the spectrographic analysis of tinnitus, recorded in esternal ear canal, taken together with the muscle movements. Palatal Myoclonus has to be considered in the etiological diagnosis of each objective tinnitus and should always be investigated properly.
Assuntos
Laringe/diagnóstico por imagem , Laringe/fisiopatologia , Movimento , Mioclonia/complicações , Mioclonia/diagnóstico por imagem , Nariz/diagnóstico por imagem , Nariz/fisiopatologia , Palato Mole/diagnóstico por imagem , Palato Mole/fisiopatologia , Zumbido/etiologia , Zumbido/fisiopatologia , Gravação em Vídeo , Doença Crônica , Meato Acústico Externo/fisiopatologia , Feminino , Humanos , Pessoa de Meia-Idade , Mioclonia/fisiopatologia , Doenças Raras , Espectrografia do SomRESUMO
Spinocerebellar ataxia 19/22 (SCA19/22) is a rare type of autosomal dominant SCA that was previously described in 11 families. We report the case of a 30-year-old Japanese man presenting with intellectual disability, early onset cerebellar ataxia, myoclonus, and dystonia without a family history. MRI showed cerebellar atrophy, and electroencephalograms showed paroxysmal sharp waves during hyperventilation and photic stimulation. Trio whole-exome sequencing analysis of DNA samples from the patient and his parents revealed a de novo novel missense mutation (c.1150G>A, p.G384S) in KCND3, the causative gene of SCA19/22, substituting for evolutionally conserved glycine. The mutation was predicted to be functionally deleterious by bioinformatic analysis. Although pure cerebellar ataxia is the most common clinical feature in SCA19/22 families, extracerebellar symptoms including intellectual disability and myoclonus are reported in a limited number of families, suggesting a genotype-phenotype correlation for particular mutations. Although autosomal recessive diseases are more common in patients with early onset sporadic cerebellar ataxia, the present study emphasizes that such a possibility of de novo mutation should be considered.
Assuntos
Ataxia Cerebelar/genética , Distonia/genética , Deficiência Intelectual/genética , Mutação/genética , Mioclonia/genética , Canais de Potássio Shal/genética , Adolescente , Ataxia Cerebelar/complicações , Ataxia Cerebelar/diagnóstico por imagem , Distonia/complicações , Distonia/diagnóstico por imagem , Eletroencefalografia , Saúde da Família , Humanos , Deficiência Intelectual/complicações , Deficiência Intelectual/diagnóstico por imagem , Imageamento por Ressonância Magnética , Masculino , Modelos Moleculares , Mioclonia/complicações , Mioclonia/diagnóstico por imagem , Degenerações Espinocerebelares/genética , Sequenciamento do ExomaRESUMO
OBJECTIVES: Unverricht-Lundborg disease (ULD) is the most common form of progressive myoclonus epilepsy. Cerebellar dysfunction may appear over time, contributing along with myoclonus to motor disability. The purpose of the present work was to clarify the motor and neurophysiological characteristics of ULD patients. METHODS: Nine patients with genetically proven ULD were evaluated clinically (medical history collected from patient charts, the Scale for the Assessment and Rating of Ataxia and Unified Myoclonus Rating Scale). Neurophysiological investigations included EEG, surface polymyography, long-loop C-reflexes, somatosensory evoked potentials, EEG jerk-locked back-averaging (JLBA) and oculomotor recordings. All patients underwent brain MRI. Non-parametric Mann-Whitney tests were used to compare ULD patients' oculomotor parameters with those of a matched group of healthy volunteers (HV). RESULTS: Myoclonus was activated by action but was virtually absent at rest and poorly induced by stimuli. Positive myoclonus was multifocal, often rhythmic and of brief duration, with top-down pyramidal temporospatial propagation. Cortical neurophysiology revealed a transient wave preceding myoclonus on EEG JLBA (n=8), enlarged somatosensory evoked potentials (n=7) and positive long-loop C-reflexes at rest (n=5). Compared with HV, ULD patients demonstrated decreased saccadic gain, increased gain dispersion and a higher frequency of hypermetric saccades associated with decreased peak velocity. CONCLUSION: A homogeneous motor pattern was delineated that may represent a ULD clinical and neurophysiological signature. Clinical and neurophysiological findings confirmed the pure cortical origin of the permanent myoclonus. Also, oculomotor findings shed new light on ULD pathophysiology by evidencing combined midbrain and cerebellar dysfunction.
Assuntos
Síndrome de Unverricht-Lundborg/fisiopatologia , Adolescente , Adulto , Idade de Início , Ataxia/etiologia , Ataxia/fisiopatologia , Encéfalo/diagnóstico por imagem , Criança , Eletroencefalografia , Eletromiografia , Potenciais Somatossensoriais Evocados , Movimentos Oculares , Feminino , Humanos , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Mioclonia/diagnóstico por imagem , Mioclonia/fisiopatologia , Exame Neurológico , Músculos Oculomotores/fisiopatologia , Movimentos Sacádicos , Síndrome de Unverricht-Lundborg/diagnóstico , Adulto JovemRESUMO
OBJECTIVE: To analyze whether KCNQ2 R201C and R201H variants, which show atypical gain-of-function electrophysiologic properties in vitro, have a distinct clinical presentation and outcome. METHODS: Ten children with heterozygous, de novo KCNQ2 R201C or R201H variants were identified worldwide, using an institutional review board (IRB)-approved KCNQ2 patient registry and database. We reviewed medical records and, where possible, interviewed parents and treating physicians using a structured, detailed phenotype inventory focusing on the neonatal presentation and subsequent course. RESULTS: Nine patients had encephalopathy from birth and presented with prominent startle-like myoclonus, which could be triggered by sound or touch. In seven patients, electroencephalography (EEG) was performed in the neonatal period and showed a burst-suppression pattern. However, myoclonus did not have an EEG correlate. In many patients the paroxysmal movements were misdiagnosed as seizures. Seven patients developed epileptic spasms in infancy. In all patients, EEG showed a slow background and multifocal epileptiform discharges later in life. Other prominent features included respiratory dysfunction (perinatal respiratory failure and/or chronic hypoventilation), hypomyelination, reduced brain volume, and profound developmental delay. One patient had a later onset, and sequencing indicated that a low abundance (~20%) R201C variant had arisen by postzygotic mosaicism. SIGNIFICANCE: Heterozygous KCNQ2 R201C and R201H gain-of-function variants present with profound neonatal encephalopathy in the absence of neonatal seizures. Neonates present with nonepileptic myoclonus that is often misdiagnosed and treated as seizures. Prognosis is poor. This clinical presentation is distinct from the phenotype associated with loss-of-function variants, supporting the value of in vitro functional screening. These findings suggest that gain-of-function and loss-of-function variants need different targeted therapeutic approaches.
Assuntos
Canal de Potássio KCNQ2/genética , Mioclonia/genética , Polimorfismo de Nucleotídeo Único/genética , Espasmos Infantis/genética , Anticonvulsivantes/uso terapêutico , Arginina/genética , Pré-Escolar , Cisteína/genética , Eletroencefalografia , Feminino , Histidina/genética , Humanos , Lactente , Recém-Nascido , Imageamento por Ressonância Magnética , Masculino , Mioclonia/diagnóstico por imagem , Mioclonia/tratamento farmacológico , Mioclonia/fisiopatologia , Fenótipo , Sistema de Registros , Transtornos Respiratórios/etiologia , Transtornos Respiratórios/genéticaRESUMO
EPM1 (epilepsy, progressive myoclonic 1; Unverricht-Lundborg disease, OMIM #254800) is the most frequent form of progressive myoclonus epilepsy. Previous findings have suggested that its pathophysiology mainly involves the cerebellum, but the evaluation of cerebellar dysfunction is still unsatisfactory. The aim of this study was to assess the structural and functional involvement of the cerebellum in EPM1. We used voxel-based morphometry and spatially unbiased infra-tentorial template analyses of structural magnetic resonance imaging (MRI) scans, and functional MRI (fMRI) scans during block and event-related go/no-go motor tasks to study 13 EPM1 patients with mild to moderate myoclonus. We compared the results with those obtained in 12 age-matched healthy controls (HCs) and in 12 patients with hereditary spinocerebellar ataxia (SCA). Structural analyses revealed different patterns of atrophic changes in the EPM1 and SCA patients: in the former, they involved both cerebrum and cerebellum but, in the latter, only the cerebellum. During fMRI, block and event-related go/no-go tasks similarly activated the cerebellum and cerebrum in the EPM1 patients and HCs, whereas both tasks revealed much less cerebellar activation in the SCA patients than in the other two groups. Volumetric evaluation of the EPM1 patients showed that the cerebellum seemed to be marginally involved in a widespread atrophic process, and fMRI showed that it was not functionally impaired during motor tasks.
Assuntos
Cerebelo/diagnóstico por imagem , Mioclonia/diagnóstico por imagem , Síndrome de Unverricht-Lundborg/diagnóstico por imagem , Adulto , Atrofia , Estudos de Casos e Controles , Cerebelo/patologia , Cerebelo/fisiopatologia , Feminino , Neuroimagem Funcional , Humanos , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Mioclonia/etiologia , Mioclonia/fisiopatologia , Síndrome de Unverricht-Lundborg/complicações , Síndrome de Unverricht-Lundborg/fisiopatologiaRESUMO
The physical examination findings of early posthypoxic myoclonus (PHM) are associated with poor prognosis. Recent findings indicate that patients with multifocal PHM, assumed to have a cortical origin, have a comparable outcome to resuscitated patients without PHM. Generalized PHM, assumed to have a subcortical myoclonus origin, is still associated with a bad clinical outcome. It is not known whether the electroencephalographic (EEG) findings differ between the multifocal and generalized myoclonus groups nor is the clinical significance clearly defined. Forty-three patients with PHM were retrospectively derived from an EEG database. Patients were categorized as having multifocal (i), generalized (ii), or undetermined (iii) PHM. Outcome was expressed in cerebral performance category scores. The EEG background was categorized into isoelectric (I), low voltage (II), burst suppression (III), status epilepticus (SE; IV), diffuse slowing (V), and mild encephalopathic or normal (VI). 17 patients had generalized PHM and 23 had multifocal PHM (3 undetermined). The EEG showed more SE in generalized compared to multifocal PHM (64% vs 13%, P< .001). Diffuse slowing was more often present in multifocal PHM (52% vs 17%, P < .05). Early-onset myoclonus occurred significantly more often in generalized PHM, and early generalized PHM was invariantly associated with poor outcome. In conclusion, patients with generalized PHM showed more SE. These EEG findings might be either subcortical corollaries or primarily cortical phenomena. Our retrospective results conflict with currently used clinical criteria for myoclonus classification, and we suggest that more refined difference may be needed for accurate assessment of PHM. To better understand PHM, prospective research with standardized clinical assessment and quantitative EEG analysis is needed.
Assuntos
Eletroencefalografia/métodos , Hipóxia/complicações , Mioclonia/diagnóstico por imagem , Adulto , Idoso , Idoso de 80 Anos ou mais , Encefalopatias/diagnóstico por imagem , Encefalopatias/etiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Mioclonia/etiologia , Mioclonia/fisiopatologia , Estudos Retrospectivos , Estado Epiléptico/diagnóstico por imagem , Estado Epiléptico/etiologia , Adulto JovemAssuntos
Encéfalo/diagnóstico por imagem , Hemimegalencefalia/complicações , Mioclonia/etiologia , Adolescente , Encéfalo/fisiopatologia , Eletroencefalografia , Hemimegalencefalia/diagnóstico por imagem , Hemimegalencefalia/fisiopatologia , Humanos , Imageamento por Ressonância Magnética , Masculino , Mioclonia/diagnóstico por imagem , Mioclonia/fisiopatologiaAssuntos
Encefalomielite/diagnóstico , Rigidez Muscular/diagnóstico , Rigidez Muscular Espasmódica/diagnóstico , Eletroencefalografia , Eletromiografia , Encefalomielite/líquido cefalorraquidiano , Encefalomielite/diagnóstico por imagem , Humanos , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Relaxantes Musculares Centrais/uso terapêutico , Rigidez Muscular/líquido cefalorraquidiano , Rigidez Muscular/diagnóstico por imagem , Mioclonia/diagnóstico por imagem , Mioclonia/etiologia , Insuficiência Respiratória/etiologia , Rigidez Muscular Espasmódica/líquido cefalorraquidiano , Rigidez Muscular Espasmódica/diagnóstico por imagem , Resultado do TratamentoRESUMO
Movement disorders have been identified as a rare early manifestation of the Moyamoya disease. Herein, we present a case of a 34-year-old man with a genetically confirmed Moyamoya disease who showed unilateral myoclonus as an initial manifestation. Neuroimaging studies showed prominent asymmetrically developed Moyamoya disease on the right hemisphere with near-complete loss of normal vessels while the left hemisphere was adjunctively fed with extension of posterior cerebral artery: uneven progression of vasculature. 99mTc-hexamethylpropylene amine oxime single-photon emission computed tomography demonstrated impaired vascular reserve. Electroencephalography showed occasional sharp waves on right temporal area. The phenomenon of this patient could be explained in the context of excitable cortex and hypoactive subcortical substrate that might imply putative contradictory neurobiology in Moyamoya disease.
Assuntos
Revascularização Cerebral , Transtornos dos Movimentos , Doença de Moyamoya , Mioclonia , Masculino , Humanos , Adulto , Doença de Moyamoya/complicações , Doença de Moyamoya/diagnóstico por imagem , Mioclonia/diagnóstico por imagem , Mioclonia/etiologia , Angiografia Cerebral , Tomografia Computadorizada de Emissão de Fóton Único , Revascularização Cerebral/métodosRESUMO
This video abstract delves into the expanded definition of diabetic striatopathy, linked initially to hyperglycemia-induced choreoballism and striatal hyperintensity on magnetic resonance imaging, but now recognized to encompass a broader range of acute onset, non-choreoballistic movement disorders in diabetes mellitus, including tremors, hemifacial spasm, parkinsonism, different types of myoclonus, dystonia, restless leg syndrome, ataxia, and dyskinesias. We report the case of a 45-year-old female patient with type-2 diabetes mellitus who developed propriospinal myoclonus, characterized by painless, involuntary jerky movements of the bilateral lower limbs in a supine position after admission for suspected rhino-orbital mucormycosis. The abnormal movements resolved entirely following the control of her blood glucose levels, suggesting a direct correlation between hyperglycemia and the clinical picture. This case highlights the importance of considering a wide range of differential diagnoses for abnormal lower limb movements in diabetic patients, emphasizing the need for accurate identification of movement semiology, routine bedside capillary blood glucose checks, and prompt hyperglycemia management to resolve such movement disorders effectively.
Assuntos
Diabetes Mellitus , Discinesias , Hiperglicemia , Transtornos dos Movimentos , Mioclonia , Feminino , Humanos , Pessoa de Meia-Idade , Mioclonia/diagnóstico por imagem , Mioclonia/etiologia , Glicemia , Discinesias/diagnóstico por imagem , Discinesias/etiologia , Hiperglicemia/complicaçõesAssuntos
Meningomielocele/complicações , Meningomielocele/cirurgia , Mioclonia/etiologia , Doenças da Medula Espinal/diagnóstico por imagem , Doenças da Medula Espinal/etiologia , Vértebras Cervicais , Humanos , Lactente , Masculino , Meningomielocele/diagnóstico por imagem , Mioclonia/diagnóstico por imagem , Mioclonia/cirurgia , Doenças da Medula Espinal/cirurgia , Vértebras Torácicas , Derivação VentriculoperitonealRESUMO
Idiopathic basal ganglia calcification (IBGC) or primary familial brain calcification is a rare genetic condition characterized by an autosomal dominant inheritance pattern and the presence of bilateral calcifications in the basal ganglia, thalami, cerebellum and cerebral subcortical white matter. The syndrome is genetically and phenotypically heterogeneous. Causal mutations have been identified in four genes: SLC20A2, PDGFRB, PDGFB and XPR1. A variety of progressive neurological and psychiatric symptoms have been described, including cognitive impairment, movement disorders, bipolar disorder, chronic headaches and migraine, and epilepsy. Here we describe a family with a novel SLC20A2 mutation mainly presenting with neurological symptoms including cortical myoclonus and epilepsy. While epilepsy, although rare, has been reported in patients with IBGC associated with SLC20A2 mutations, cortical myoclonus seems to be a new manifestation.
Assuntos
Doenças dos Gânglios da Base , Encefalopatias , Epilepsia , Mioclonia , Epilepsia/complicações , Epilepsia/diagnóstico por imagem , Epilepsia/genética , Humanos , Mutação/genética , Mioclonia/diagnóstico por imagem , Mioclonia/genética , Linhagem , Proteínas Cotransportadoras de Sódio-Fosfato Tipo III/genética , Receptor do Retrovírus Politrópico e XenotrópicoRESUMO
OBJECTIVE: To examine the prognostic ability of the combination of EEG and MRI in identifying patients with good outcome in postanoxic myoclonus (PAM) after cardiac arrest (CA). METHODS: Adults with PAM who had an MRI within 20 days after CA were identified in 4 prospective CA registries. The primary outcome measure was coma recovery to command following by hospital discharge. Clinical examination included brainstem reflexes and motor activity. EEG was assessed for best background continuity, reactivity, presence of epileptiform activity, and burst suppression with identical bursts (BSIB). MRI was examined for presence of diffusion restriction or fluid-attenuated inversion recovery changes consistent with anoxic brain injury. A prediction model was developed using optimal combination of variables. RESULTS: Among 78 patients, 11 (14.1%) recovered at discharge and 6 (7.7%) had good outcome (Cerebral Performance Category < 3) at 3 months. Patients who followed commands were more likely to have pupillary and corneal reflexes, flexion or better motor response, EEG continuity and reactivity, no BSIB, and no anoxic injury on MRI. The combined EEG/MRI variable of continuous background and no anoxic changes on MRI was associated with coma recovery at hospital discharge with sensitivity 91% (95% confidence interval [CI], 0.59-1.00), specificity 99% (95% CI, 0.92-1.00), positive predictive value 91% (95% CI, 0.59-1.00), and negative predictive value 99% (95% CI, 0.92-1.00). CONCLUSIONS: EEG and MRI are complementary and identify both good and poor outcome in patients with PAM with high accuracy. An MRI should be considered in patients with myoclonus showing continuous or reactive EEGs.